AGO-OVAR 16: A phase III study to evaluate the efficacy and safety of pazopanib (PZ) monotherapy versus placebo in women who have not progressed after first line chemotherapy for epithelial ovarian, fallopian tube, or primary peritoneal cancer—Overall survival (OS) results

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 36; no. 15_suppl; p. 5518
Main Authors:	Vergote, Ignace, Hanker, Lars Christian, Floquet, Anne, Rau, Joern, Kim, Jae-Weon, Ortega Izquierdo, Eugenia, Friedlander, Michael, Pignata, Sandro, Fujiwara, Keiichi, Colombo, Nicoletta, Mirza, Mansoor Raza, Monk, Bradley J., Mörtl, Manfred, Calvert, Paula, Herzog, Thomas J., Jackisch, Christian, Meunier, Jérome, Lee, Jung-Yun, Belau, Antje Kristina, Du Bois, Andreas
Format:	Journal Article
Language:	English
Published:	20-05-2018
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!